Global Health & Medicine
Online ISSN : 2434-9194
Print ISSN : 2434-9186
Pathologic myopia: an overview of the current understanding and interventions
Takashi UetaSo MakinoYuuka YamamotoHarumi FukushimaShigeko YashiroMiyuki Nagahara
Author information

2020 Volume 2 Issue 3 Pages 151-155


Pathologic myopia is a major cause of low vision and blindness worldwide. Its social and economic burden has been demonstrated by epidemiological studies. There have been recent advances in the classification system for myopic maculopathy that enables clinicians to describe different types of lesions, including tessellated fundus, diffuse/patchy chorioretinal atrophy, macular atrophy, lacquer cracks, choroidal neovascularization (CNV), and Fuchs' spot, in a standardized format. From a therapeutic point of view, anti-vascular endothelial growth factor therapy has been established as first-line choice for myopic CNV. For myopic retinoschisis and macular holes with/without retinal detachment, pars plana vitrectomy has been generally accepted as an efficient strategy. Studies are being conducted to determine how to avoid the development of a postoperative macular hole and to improve the quality of vision after surgery. In recent years, studies have revealed preventive measures that can be taken against myopia progression, including low-dose atropine eyedrops and contact lens wearing with peripheral myopic defocusing.

Information related to the author
© 2020 National Center for Global Health and Medicine
Next article